2011
DOI: 10.1016/j.jaad.2010.05.030
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of cutaneous angioimmunoblastic T-cell lymphoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
61
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(63 citation statements)
references
References 50 publications
1
61
1
Order By: Relevance
“…15,[20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35] Clinically, primary cutaneous CD4( þ ) small/ medium-sized pleomorphic T-cell lymphoma and angioimmunoblastic T-cell lymphoma present or may present with primary cutaneous involvement. 20,[36][37][38][39][40] Other CD4( þ ) T-cell lymphomas with primary cutaneous manifestations include mycosis fungoides and its variants including Sezary syndrome, adult T-cell leukemia/lymphoma and primary cutaneous CD30 þ lymphoproliferative disorders. 41 CD10 has not been reported to be a feature of mycosis fungoides or Sezary syndrome.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…15,[20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35] Clinically, primary cutaneous CD4( þ ) small/ medium-sized pleomorphic T-cell lymphoma and angioimmunoblastic T-cell lymphoma present or may present with primary cutaneous involvement. 20,[36][37][38][39][40] Other CD4( þ ) T-cell lymphomas with primary cutaneous manifestations include mycosis fungoides and its variants including Sezary syndrome, adult T-cell leukemia/lymphoma and primary cutaneous CD30 þ lymphoproliferative disorders. 41 CD10 has not been reported to be a feature of mycosis fungoides or Sezary syndrome.…”
mentioning
confidence: 99%
“…20,34 Angioimmunoblastic T-cell lymphoma is an aggressive nodal-based disease that involves skin in roughly 50% of individuals. [38][39][40] The neoplastic T cells in angioimmunoblastic T-cell lymphoma express the follicular center helper T-cell markers CD10, PD-1, and CXCL-13 in the majority of cases. 27,[41][42][43] Angioimmunoblastic T-cell lymphoma is also notable for an association with EBV as 70% or more angioimmunoblastic T-cell lymphoma lesions contain EBV( þ ) B cells, a finding helpful in establishing the diagnosis.…”
mentioning
confidence: 99%
“…[21][22][23] It is also present in the majority of cases of early stage adult T-cell leukemia/lymphoma (ATLL) 31,32 and type B lymphomatoid papulosis (LYP). 16 However, epidermotropism is either absent or variably seen in other non-MF CTCLs included in WHO classification 14,15,[17][18][19][20][24][25][26][27][28][29][30]33 (Table 2). In 2 different studies, epidermotropism was absent in 60% and 79% of non-MF CTCL cases.…”
Section: Epidermotropismmentioning
confidence: 99%
“…Skin rashes are associated with AITL in 50–80% of patients 2,1017 . Typically, the rash is morbilliform, and less commonly purpuric, urticarial, nodular or petechial.…”
Section: Introductionmentioning
confidence: 99%
“…Typically, the rash is morbilliform, and less commonly purpuric, urticarial, nodular or petechial. Pruritus can be seen in up to 84% of cases 10 . It is now accepted that AITL derives from a population of regulatory T-cells, called follicular T-helper cells (T FH ), that express PD1, CD10, BCL6, and CXCL13 and whose normal function is to induce B-cell activation in the germinal center.…”
Section: Introductionmentioning
confidence: 99%